Schizophrenia Research
Volume 81, Issue 1 , Pages 1-15 , 1 January 2006

One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia

  • Richard S.E. Keefe

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC 27710, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 919 684 4306; fax: +1 919 684 2632.
    • ,
  • Carrie A. Young

      Affiliations

    • Lilly Research Laboratories, Indianapolis, IN US 46285, United States
    • ,
  • Stephanie L. Rock

      Affiliations

    • Lilly Research Laboratories, Indianapolis, IN US 46285, United States
    • ,
  • Scot E. Purdon

      Affiliations

    • Department of Psychiatry, University of Alberta, CHA-ANE, Box 307, Edmonton, Alberta, Canada T5J 2J7
    • ,
  • James M. Gold

      Affiliations

    • Maryland Psychiatric Research Center, University of Maryland Baltimore, School of Medicine, P.O. Box 21247, Baltimore, MD 21228, USA
    • ,
  • Alan Breier

      Affiliations

    • Lilly Research Laboratories, Indianapolis, IN US 46285, United States
    • ,
  • HGGN Study Group

      Affiliations

    • Consisted of all authors and others, who participated in the design and execution of HGGN study partially funded by Lilly Research Laboratories.

Received 21 February 2005 ,Revised 27 July 2005 ,Accepted 29 July 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Colleogium Internationale Neuro-Psychopharmacologicum annual meeting June 23–27, 2002; Montreal, Canada; European College on Neuropsychpharmacology annual meeting October 5–9, 2002; Barcelona, Spain; American College Of Neuropsychopharmacology annual meeting December 8–12, 2002; San Juan, Puerto Rico; International Congress on Schizophrenia Research annual meeting March 29–April 2, 2003; Colorado Springs, CO, USA.

PII: S0920-9964(05)00355-5

doi: 10.1016/j.schres.2005.07.038

Schizophrenia Research
Volume 81, Issue 1 , Pages 1-15 , 1 January 2006

Article Tools

* Image Usage & Resolution